[1]崔敏珺,李從圣,楊 靜.高血壓患者發生射血分數保留心衰的危險因素分析[J].醫學信息,2019,(20):72-76.[doi:10.3969/j.issn.1006-1959.2019.20.020]
 CUI Min-jun,LI Cong-sheng,YANG Jing.Analysis of Risk Factors for the Occurrence of Heart Failure in Patients with Hypertension[J].Medical Information,2019,(20):72-76.[doi:10.3969/j.issn.1006-1959.2019.20.020]
點擊復制

高血壓患者發生射血分數保留心衰的危險因素分析()
分享到:

醫學信息[ISSN:1006-1959/CN:61-1278/R]

卷:
期數:
2019年20期
頁碼:
72-76
欄目:
論著
出版日期:
2019-10-15

文章信息/Info

Title:
Analysis of Risk Factors for the Occurrence of Heart Failure in Patients with Hypertension
文章編號:
1006-1959(2019)20-0072-05
作者:
崔敏珺李從圣楊 靜
(安徽省合肥市第一人民醫院急診內科,安徽 合肥 230061)
Author(s):
CUI Min-junLI Cong-shengYANG Jing
(Department of Emergency Internal,Hefei First People's Hospital,Anhui 230061,Hefei,China)
關鍵詞:
高血壓射血分數保留心衰危險因素
Keywords:
HypertensionEjection fraction preserves heart failureRisk factors
分類號:
R541.6
DOI:
10.3969/j.issn.1006-1959.2019.20.020
文獻標志碼:
A
摘要:
目的 分析高血壓患者發生射血分數保留心力衰竭的危險因素,為該類患者的預防提供參考依據。方法 回顧性分析2016年1月~2018年12月我院102例原發性高血壓患者的臨床資料,將高血壓合并射血分數保留的心力衰竭患者50例作為觀察組,以原發性高血壓非心衰患者52例作為對照組,比較兩組臨床資料,包括性別、年齡、BMI、吸煙史、飲酒史、房顫、冠心病、糖尿病、高尿酸血癥、腎功能不全、腦卒中、低血鉀、血脂異常、貧血、呼吸睡眠暫停病史,分析其與高血壓合并射血分數保留心衰的相關性,多因素回歸分析高血壓患者發生射血分數保留心衰的危險因素。結果 兩組性別、BMI、年齡、吸煙史、房顫、冠心病、糖尿病、高尿酸血癥、腎功能不全、貧血的發病率比較,差異有統計學意義(P<0.05);兩組飲酒史、低血鉀、腦卒中、血脂異常、呼吸睡眠暫停發病率比較,差異無統計學意義(P>0.05)。Pearson相關性分析結果顯示,性別、BMI、年齡,吸煙史、房顫、冠心病、糖尿病、高尿酸血癥、腎功能不全、貧血與高血壓合發生射血分數保留心衰呈正相關(P<0.05)。Logistic多因素回歸分析結果顯示,女性、超重、吸煙、房顫、高尿酸血癥為高血壓患者發生射血分數保留心衰的獨立危險因素。結論 女性、超重、吸煙、房顫、高尿酸血癥為高血壓合并射血分數保留心衰的危險因素。臨床工作應重視對女性高血壓患者基礎疾病控制,同時重視對患者不良生活習慣的干預治療,改善機體異常癥狀,以降低射血分數保留心衰的發生進展。
Abstract:
Objective Analysis of the risk factors of heart failure in patients with hypertension to preserve heart failure, provide a reference for the prevention of such patients.Methods A retrospective analysis of 102 patients with essential hypertension admitted to our hospital from January 2016 to December 2018, 50 patients with heart failure and hypertension with ejection fraction retained as observation group, with essential hypertension 52 patients with non-heart failure were used as the control group. The clinical data, including sex, age, BMI, smoking history, drinking history, atrial fibrillation, coronary heart disease, diabetes, hyperuricemia were compared between the two groups, renal insufficiency, stroke, hypokalemia, dyslipidemia, anemia, respiratory sleep apnea history, analysis of its association with hypertension with ejection fraction to preserve heart failure, multivariate regression analysis of high blood pressure patients with ejection fraction Preserve the risk factors for heart failure.Results There were significant differences in gender, BMI, age, and smoking history and the incidence of atrial fibrillation, coronary heart disease, diabetes, hyperuricemia, renal insufficiency, and anemia was statistically significant (P<0.05). There was no significant difference in the incidence of drinking history, hypokalemia, stroke, dyslipidemia, and respiratory sleep pauses between two groups (P>0.05). Pearson correlation analysis showed that gender, BMI, age, smoking history, atrial fibrillation, coronary heart disease, diabetes, hyperuricemia, renal insufficiency, anemia and hypertension were positively correlated with the ejection fraction to preserve heart failure (P<0.05). Logistic multivariate regression analysis showed that women, overweight, smoking, atrial fibrillation, and hyperuricemia were independent risk factors for the occurrence of heart failure in patients with hypertension.Conclusion Female, overweight, smoking, atrial fibrillation, and hyperuricemia are risk factors for hypertension and combined ejection fraction to preserve heart failure. Clinical work should pay attention to the basic disease control of female hypertensive patients, and pay attention to the intervention treatment of patients with bad living habits, improve the abnormal symptoms of the body, in order to reduce the ejection fraction and preserve the progress of heart failure.

參考文獻/References:

[1]Ponikowski P,Voors AA,Anker SD,et al.2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure:The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology(ESC)Developed with the special contribution of the Heart Failure Association(HFA)of the ESC[J].Eur Heart J,2016,18(8):891-975. [2]Forouzanfar MH,Liu P,Roth GA,et al.Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mmHg,1990-2015[J].JAMA,2017,317(2):165-182. [3]孫剛,黃冠華.高血壓合并心力衰竭的治療策略[J].心血管病學進展,2016,37(2):201-204. [4]田桂芳,楊秀玲,戴妍妍,等.射血分數保留的老年慢性心力衰竭患者的N末端腦鈉肽前體水平及超聲特點[J].中國循證心血管醫學雜志,2017,9(3):345-347. [5]Expert Panel on Detection,Evaluation,and Treatment of High Blood Cholesterol in Adults.Executive summary of the National Cholesterol Education Program(NCEP)expert panel on detection,evaluation,and treatment of high blood cholesterol in adults(Adult Treatment Panel Ⅲ)[J].JAMA,2001,285(19),2486-2479. [6]趙昔良,葉益聰,張抒揚.美國糖尿病學會新版糖尿病診斷標準對擇期冠狀動脈造影患者糖代謝異常的篩查意義[J].中華內科雜志,2015,54(4):302-306. [7]Hoste L,Dubourg L,Selistre L,et al.A new equation to estimate the glomerular filtration rate in children,adolescents and young adults[J].Nephrol Dial Transplant,2014,29(5):1082-1091. [8]嚴玉平,伍桂枝.尿酸、高尿酸血癥與缺血性卒中[J].國際腦血管病雜志,2014,22(5):392-396. [9]Greenberg B.Heart failure preserved ejection fraction with coronary artery disease:time for a new classification[J].J Am Coll Cardiol,2014,63(25 Pt A):2828-2830. [10]Remme WJ,Swedberg K.Guidelines for the diagnosis and treatment of chronic heart failure[J].Eur Heart J,2001,22(17):1527-1560. [11]Kristensen SL,Mogensen UM,Jhund PS,et al.Clinical and Echocardioraphic Characteristics and Cardiovascular Outcomes According to Diabetes Status in Patients With Heart Failure and Preserved Ejection Fraction:A Report From the I-preserve Trial(Irbesartan in Heart Failure With Preserved Ejection Fraction)[J].Circulation,2017,135(8):742-735. [12]潘慶麗.高血壓患者并發心力衰竭的危險因素分析[J].慢性病學雜志,2016,17(9):1047-1049. [13]左易霞,范晉奇,殷躍輝,等.射血分數保留的心力衰竭新進展[J].心血管病學進展,2017,38(1):21-24. [14]Guo L,Guo X,Chang Y,et al.Prevalence and Risk Factors of Heart Failure with Preserved Ejection Fraction:A Population-Based Study in Northeast China[J].Environmental Research and Public Health,2016,13(8):E770. [15]王淼,張強,王義圍,等.老年患者射血分數保留心力衰竭與N端腦鈉肽前體、超敏C反應蛋白、血尿酸及同形半胱氨酸的相關性[J].中國老年醫學,2017,37(2):366-368. [16]Chen Y,Sato H,Watanabe N,et al.Factors influencing left atrial volume in treated hypertension[J].J Cardiol,2012,60(2):133-138. [17]Anter E,Jessup M,Callans DJ.Atrial fibrillation and heart failure:treatment considerations for a dual epidemic[J].Circulation,2009,119(18):2516-2525. [18]宋婷婷,賈紅丹,國強華,等.老年高血壓患者發生射血分數保留心衰的危險因素分析[J].川北醫學院學報,2018,33(2):158-161. [19]于彤彤,劉雙雙,王箐箐,等.舒張性和收縮性心衰患者的臨床表現差異分析[J].天津醫藥,2015,34(1):68-71. [20]Oluleye OW,Rector TS,Win S,et al.History of atrial fibrillation as a risk factor in patients with heart failure and preserved ejection fraction[J].Circ Heart Fail,2014,7(6):960-966. [21]常彬賓,王建,徐超.左室射血分數保留的高齡心衰貧血患者的分析[J].臨床醫藥文獻雜志,2018,5(51):31-33. [22]常彬賓,許婷媛,徐賢華,等.鐵缺乏對左室射血分數的高齡心衰患者生活質量的影響[J].西南國防醫藥,2018,28(7):612-614.

相似文獻/References:

[1]顏 明,龔麗娜,王淑清.彩超在高血壓患者腎動脈血流動力學檢測中的應用分析[J].醫學信息,2018,(02):156.[doi:10.3969/j.issn.1006-1959.2018.02.060]
 YAN Ming,GONG Li-na,WANG Shu-qing.Application of Color Doppler Ultrasound in the Measurement of Renal Artery Hemodynamics in Patients with Hypertension[J].Medical Information,2018,(20):156.[doi:10.3969/j.issn.1006-1959.2018.02.060]
[2]夏能能,任 薇,杜建平,等.1953~2016年中醫藥治療高血壓領域研究熱點分析[J].醫學信息,2018,(04):18.[doi:10.3969/j.issn.1006-1959.2018.04.007]
 XIA Neng-neng,REN Wei,DU Jian-ping,et al.Analysis of Hot Spots in the Research of Traditional Chinese Medicine in Treating Hypertension from 1953 to 2016[J].Medical Information,2018,(20):18.[doi:10.3969/j.issn.1006-1959.2018.04.007]
[3]靳雪芹,鄧正聰.代謝綜合征與腫瘤關系的研究進展[J].醫學信息,2018,(05):35.[doi:10.3969/j.issn.1006-1959.2018.05.014]
 JIN Xue-qin,DENG Zheng-cong.Research Progress on the Relationship between Metabolic Syndrome and Tumor[J].Medical Information,2018,(20):35.[doi:10.3969/j.issn.1006-1959.2018.05.014]
[4]喬 君,高 翔,王 瑜,等.纈沙坦對原發性高血壓患者外周PBMC中IL-17表達的影響[J].醫學信息,2018,(07):65.[doi:10.3969/j.issn.1006-1959.2018.07.021]
 QIAO Jun,GAO Xiang,WANG Yu,et al.The Effect of Valsartan on the Expression of IL-17 in Peripheral PBMC of Patients with Essential Hypertension[J].Medical Information,2018,(20):65.[doi:10.3969/j.issn.1006-1959.2018.07.021]
[5]董巧玲.健康教育對原發性高血壓患者治療效果的影響[J].醫學信息,2018,(09):180.[doi:10.3969/j.issn.1006-1959.2018.09.060]
 DONG Qiao-ling.Effect of Health Education on Treatment of Patients with Essential Hypertension[J].Medical Information,2018,(20):180.[doi:10.3969/j.issn.1006-1959.2018.09.060]
[6]沈 正,王慶海.焦慮抑郁障礙與血壓變異性研究[J].醫學信息,2018,(16):34.[doi:10.3969/j.issn.1006-1959.2018.16.010]
 SHEN Zheng,WANG Qing-hai.Study on Anxiety and Depression Disorder and Blood Pressure Variability[J].Medical Information,2018,(20):34.[doi:10.3969/j.issn.1006-1959.2018.16.010]
[7]左洪亮.苯磺酸左旋氨氯地平片治療中老年患者 輕中度原發性高血壓的療效觀察[J].醫學信息,2018,(16):120.[doi:10.3969/j.issn.1006-1959.2018.16.037]
 ZUO Hong-liang.Efficacy of Levamlodipine Besylate Tablets in Treatment of Mild to Moderate Essential Hypertension in Middle-aged and Elderly Patients[J].Medical Information,2018,(20):120.[doi:10.3969/j.issn.1006-1959.2018.16.037]
[8]袁 敏,周袁成.鈣離子拮抗劑類降壓藥的臨床應用與不良反應分析[J].醫學信息,2018,(17):125.[doi:10.3969/j.issn.1006-1959.2018.17.038]
 YUAN Min,ZHOU Yuan-cheng.Clinical Application and Adverse Reaction Analysis of Calcium Antagonist Antihypertensive Drugs[J].Medical Information,2018,(20):125.[doi:10.3969/j.issn.1006-1959.2018.17.038]
[9]陳學軍,李 敏,張 丹,等.社區一體化分級管理模式對社區老年高血壓患者的管理效果[J].醫學信息,2018,(18):169.[doi:10.3969/j.issn.1006-1959.2018.18.055]
 CHEN Xue-jun,LI Min,ZHANG Dan,et al.Management Effect of Community Integration Hierarchical Management Mode on Elderly Hypertensive Patients in Community[J].Medical Information,2018,(20):169.[doi:10.3969/j.issn.1006-1959.2018.18.055]
[10]張莉莉.左旋氨氯地平和氨氯地平治療輕中度高血壓臨床效果觀察[J].醫學信息,2018,(21):149.[doi:10.3969/j.issn.1006-1959.2018.21.043]
 ZHANG Li-li.Clinical Efficacy of Levamlodipine and Amlodipine in Treatment of Mild to Moderate Hypertension[J].Medical Information,2018,(20):149.[doi:10.3969/j.issn.1006-1959.2018.21.043]

更新日期/Last Update: 2019-10-15
重庆时时开奖号码k线图